Sweet news for mango farmers in Karnataka, Centre announces MSP
KOLAR: The Union government on Tuesday announced a minimum support price (MSP) for mangoes, bringing relief to thousands of farmers in Karnataka, who had been affected by crop loss and drastic fall in prices this year.
The Centre approved a price of Rs 1,616 per quintal and allowed the state government to procure 2,50,000 metric tonnes of mangoes for this marketing year. The Centre's decision followed a letter written by Union Minister of Heavy Industries and Steel HD Kumaraswamy to Union Minister for Agriculture and Farmer Welfare Shivaraj Singh Chouhan, requesting assistance to farmers. Former PM HD Deve Gowda too had written on Monday to PM Narendra Modi to come to the aid of mango farmers.
Replying to Kumaraswamy's letter, Chouhan announced the Market Intervention Scheme (MIS) for mangoes on Tuesday.
Immediately, Kumaraswamy posted on X, thanking Modi for the 'unwavering and farmer-centric commitment' of the central government.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
41 minutes ago
- Time of India
Samsung Galaxy Z Fold 7, Galaxy Z Flip 7 pre-reservation begin in India: Here's how you can pre-reserve the upcoming foldable smartphones
Samsung recently announced its Galaxy Unpacked 2025 event will take place on July 9 in Brooklyn, New York, at 10:00 AM ET (7:30 PM IST), where the tech giant is expected to unveil its next-generation Galaxy Z Fold 7 and Galaxy Z Flip 7 smartphones featuring a revolutionary AI-powered interface. The event will be livestreamed on Samsung's website and YouTube channel. The company has now started pre-reservation for its upcoming flagship foldable smartphone series in India. Samsung Galaxy Z Fold 7, Galaxy Z Flip 7 pre-reservation starts in India Samsung has now started pre-reservation for the upcoming Galaxy Z Fold 7 and Galaxy Z Flip 7 in India. The company has announced that customers can pre-reserve the upcoming foldable smartphones by paying a token amount of Rs 2,000. The company has also revealed that the customers who will pre-reserve the smartphone will get benefit worth Rs 5,999 on the purchase. Along with this, the customers will also be eligible for early delivery. Customers can pre-reserve the devices by visiting Samsung Exclusive Stores , and leading retail outlets across India. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Trade Bitcoin & Ethereum – No Wallet Needed! IC Markets Start Now Undo What to expect at Samsung's Galaxy Unpacked July Expected product launches include the Galaxy Z Fold7, rumored to feature Samsung's largest foldable display yet at 8.2 inches, surpassing competitors. The Galaxy Z Flip7 will reportedly be powered by Samsung's newly introduced Exynos 2500 Deca-Core processor and come in jet black, blue shadow, and coral red variants. A more affordable Galaxy Z Flip 7 FE model is also anticipated. Beyond smartphones, Samsung is expected to expand its wearables portfolio with the Galaxy Watch 8 series, including standard, Classic, and Ultra 2025 models. The recently teased Galaxy Buds Core may also debut at the event. Additional announcements may include updates on Project Moohan, Samsung's collaboration with Google on extended reality headsets, and the company's rumored tri-fold smartphone development.
Business Standard
42 minutes ago
- Business Standard
SEPC successfully raises Rs 350 cr via rights issue
SEPC announced that it has achieved successful closure of rights issue of 74,35,19,173 partly paid-up equity shares aggregating to Rs 350 crore having issue price of Rs 10/- per equity share (including a share premium of Rs nil per share) (the issue price) on a rights basis to the eligible equity shareholders of our Company closed successfully on 23 June by Capital Market - Live News
Business Standard
42 minutes ago
- Business Standard
Lupin receives USFDA approval for generic Prucalopride tablets
Lupin announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its abbreviated new drug application (ANDA) for Prucalopride tablets. The tablets are a generic equivalent of Motegrity Tablets, developed by Takeda Pharmaceuticals U.S.A., Inc., and are indicated for the treatment of chronic idiopathic constipation (CIC) in adults. Lupin stated that the approved product is bioequivalent to Motegrity and will be manufactured at the companys facility in Goa, India. According to IQVIA MAT data for April 2025, Prucalopride Tablets (Reference Listed Drug: Motegrity) had estimated annual sales of approximately $184 million in the United States. Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. The companys consolidated net profit surged 114.9% to Rs 772.52 crore on a 13.6% jump in net sales to Rs 5,562.20 crore in Q4 FY25 over Q4 FY24. The scrip rose 0.07% to Rs 1,932.10 on the BSE.
